EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Directed evolution expands CRISPR–Cas12a genome-editing capacity

Enbo Ma iD, Kai Chen iD, Honglue Shi iD, Kevin M Wasko, Isabel Esain-Garcia, Marena I Trinidad, Kaihong Zhou, Jinjuan Ye, Jennifer A Doudna iD

Nucleic Acids Research · 08.07.2025 · 53 (13)

DOI: 10.1093/nar/gkaf649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 16.07.2025. Verfasst von Enbo Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, United States. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, CRISPR-Associated Proteins, Directed Molecular Evolution. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Life Sciences Research Foundation, NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR–Cas12a enzymes are versatile RNA-guided genome-editing tools with applications encompassing viral diagnosis, agriculture, and human therapeutics. However, their dependence on a 5′-TTTV-3′ protospacer adjacent motif (PAM) next to DNA target sequences restricts Cas12a’s gene targeting capability to only ∼1% of a typical genome. To mitigate this constraint, we used a bacterial-based directed evolution assay combined with rational engineering to identify variants of Lachnospiraceae bacterium Cas12a with expanded PAM recognition. The resulting Cas12a variants use a range of noncanonical PAMs while retaining recognition of the canonical 5′-TTTV-3′ PAM. In particular, biochemical and cell-based assays show that the variant Flex-Cas12a utilizes 5′-NYHV-3′ PAMs that expand DNA recognition sites to ∼25% of the human genome. With enhanced targeting versatility, Flex-Cas12a unlocks access to previously inaccessible genomic loci, providing new opportunities for both therapeutic and agricultural genome engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingCRISPR-Associated ProteinsDirected Molecular EvolutionEndodeoxyribonucleasesBacterial ProteinsHumansGenome, Human

Substanzen

CRISPR-Associated ProteinsCas12a proteinEndodeoxyribonucleasesBacterial Proteins

Autor:innen und Institutionen

  • Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, United States.
  • Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, United States.
  • Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, United States.
  • California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, CA 94720, United States.
  • Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, United States.
  • Li Ka Shing Center for Genomic Engineering, University of California, Berkeley, Berkeley, CA 94720, United States.

ORCID-Profile: Enbo Ma, Kai Chen, Honglue Shi, Jennifer A Doudna

Förderung

  • Life Sciences Research Foundation
  • NIH HHS
  • NHLBI NIH HHS
  • DOE
  • Mr Li Ka Shing
  • Howard Hughes Medical Institute
  • NIAID NIH HHS
  • Emerson Collective

Zitieren

APA

Ma, E., Chen, K., Shi, H., Wasko, K. M., Esain-Garcia, I., Trinidad, M. I., Zhou, K., Ye, J., & Doudna, J. A. (2025). Directed evolution expands CRISPR–Cas12a genome-editing capacity. Nucleic Acids Research, 53(13). https://doi.org/10.1093/nar/gkaf649

Vancouver

Ma E, Chen K, Shi H, Wasko KM, Esain-Garcia I, Trinidad MI, et al. Directed evolution expands CRISPR–Cas12a genome-editing capacity. Nucleic Acids Research. 2025;53(13). doi:10.1093/nar/gkaf649

BibTeX
@article{Ma2025,
  author = {Ma, Enbo and Chen, Kai and Shi, Honglue and Wasko, Kevin M and Esain-Garcia, Isabel and Trinidad, Marena I and Zhou, Kaihong and Ye, Jinjuan and Doudna, Jennifer A},
  title = {Directed evolution expands CRISPR–Cas12a genome-editing capacity},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {13},
  doi = {10.1093/nar/gkaf649}
}
Kostenlos starten →